Patent · US Active

Functionalised silicon nanoparticles

US10130588B2 · kind B2 · utility

1Cited by
0References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 12, 2012
Grant dateNov 20, 2018
Priority date
Expiry dateDec 12, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T428/2982
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is related to silicon nanoparticles, a pharmaceutical composition comprising silicon nanoparticles, a method for synthesis of the silicon nanoparticles and their use for in vivo diagnostics, visualization of drug delivery or staining of cells, biological processes or pathways. The silicon nanoparticles are characterized that they comprise a silicon core of a size of 1 to 10 nm and are terminated with allylamine or poly(allylamine) comprising up to 10 allylamine groups.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.